Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction and STI in Acute HIV (ACTG 371)
NCT00000940Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lamivudine, stavudine, abacavir, amprenavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started May 1999; status: completed.
02
Drugs
lamivudinestavudineabacaviramprenavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000940.